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Introduction {#sec1}
============

Skin morphogenesis is a complex process requiring the spatial and temporal orchestration of distinct molecular signaling pathways to ensure correct development of epidermal lineages such as interfollicular epidermis (IFE), hair follicles (HF), and sebaceous glands. Initiation of HF development is mainly conducted by β-catenin and SHH signaling ([@bib19], [@bib4], [@bib18]), resulting in formation of hair placodes between embryonic day (E)15 and E17 ([@bib50]). After the critical step of placode formation, SHH stimulates proliferation of cells within this structure, which then grow down into the dermis as hair germs and further develop into hair pegs between E17 and E18 ([@bib18]). Continuous growth of the hair peg leads to the formation of a mature HF, which is constituted of highly proliferative progenitor cells, the so-called matrix, at the bottom. Progeny of the matrix gives rise to the distinct differentiated epithelial cell layers, which comprise the hair or function in hair guidance ([@bib18], [@bib1]). The cell layers from the outer to innermost layer are outer root sheath (ORS), companion layer, three layers of inner root sheath (IRS), cuticle, cortex, and medulla. WNT/β-catenin and bone morphogenetic protein (BMP) signaling were shown to orchestrate hair layer differentiation by temporal layering of signaling effectors ([@bib1]). Impairment in the formation of solely one layer is sufficient to induce the collapse of the hair shaft and sustained disruption of hair development ([@bib8], [@bib21]).

Besides instructive Wnt/β-catenin and BMP signaling pathways, epidermal growth factor receptor (EGFR) signaling strongly contributes to skin development and homeostasis of mice and humans. Mice completely lacking EGFR are born with open eyes and display severe skin defects, including a pronounced delay in HF development ([@bib34], [@bib44], [@bib49]). Expression of a dominant-negative mutant of EGFR in keratinocytes ([@bib36]) and hair transplantation experiments ([@bib15]) revealed that EGFR-deficient HFs are able to progress through morphogenesis for about 2 weeks after birth, but then fail to enter catagen. Similarly, humanized EGFR mice (*hEGFR*^*KI/KI*^) exhibit impaired HF morphogenesis, alterations in morphology and distribution of HFs, and a failure in anagen to catagen transition owing to inefficient expression of the *hEGFR* in the skin ([@bib43]). At postnatal day (P)90, *hEGFR*^*KI/KI*^ mice mostly contained degenerated HFs with thin hair cell layers, which were partly destroyed. Later, studies in conditional knockout mice lacking the EGFR specifically in the epidermal lineage ([@bib37], [@bib27], [@bib31], [@bib3]) confirmed that loss of EGFR in keratinocytes is sufficient to induce skin differentiation defects, catagen block, loss of the HF niche, and baldness. Moreover, epidermis-specific EGFR knockout results in severe skin inflammation and confers high susceptibility to *S. aureus* infections. Similar phenotypes have also been observed in cancer patients receiving anti-EGFR therapies ([@bib27], [@bib31]). In contrast, mice harboring either the naturally occurring EGFR mutation *waved2* ([@bib29]) or the transforming growth factor (TGF)-α mutation *waved1* ([@bib6], [@bib30]) only show a mild phenotype characterized by wavy hair coat and whiskers but otherwise normal physiology. TGFα shows specific expression in cells of the IRS ([@bib30]), suggesting an important role of EGFR signaling in the control of epithelial hair layer development and hair shape, whereas EREG and AREG have been shown to affect sebocyte numbers or sebaceous gland size ([@bib7], [@bib26]).

So far it has been poorly investigated how much the skin inflammation developing in the absence of epidermal EGFR affects the stem cell compartments thus aggravating the resulting phenotypes. Therefore in this study we employed conditional mouse models allowing us to dissect the cell-autonomous functions of EGFR signaling in distinct keratinocyte and stem cell compartments independently of the non-cell-autonomous contribution of inflammation. Our results indicate that EGFR signaling ensures DNA integrity in proliferative compartments, where accumulation of DNA damage results in TP53-dependent cell death. Moreover, we demonstrate that EGFR controls transcription factor expression in the innermost epithelial hair lineages, which is required for hair shaft differentiation.

Results {#sec2}
=======

Previous studies have shown that skin-specific genetic ablation of EGFR during murine embryonic development causes profound defects of HF morphogenesis, but so far lacked detailed mechanistic analysis. Developing HFs need to go through several sequential phases to give rise to a mature HF ([Figure 1](#fig1){ref-type="fig"}A). To specifically investigate the function of EGFR signaling during the specification and growth phase of HF morphogenesis, *Egfr*^*fl/fl*^ mice ([@bib40]) were crossed with *K5Cre* transgenic mice to generate mice lacking the EGFR already during embryonic development in the epidermal lineage (*Egfr*^*Δep*^ mice, [Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B; [Table S3](#mmc4){ref-type="supplementary-material"}; [@bib27]). Time course analysis during the growth, catagen, and telogen phases of HFs showed that *Egfr*^*Δep*^ mice present a significant delay in HF growth ([Figures 1](#fig1){ref-type="fig"}B--1D), a catagen block ([Figures 1](#fig1){ref-type="fig"}C and 1D), and hair shape alterations ([Figure S1](#mmc1){ref-type="supplementary-material"}C).Figure 1EGFR Deficiency Does Not Result in Alterations of HF Specification during Morphogenesis(A) Schematic time course of HF morphogenesis.(B) HF morphogenesis staging from control and *Egfr*^*Δep*^ mice at P1. Bars show analysis of 15--20 follicles per mouse from n = 3 mice per genotype. Data are represented as mean ± SD. p values less than 0.05 were considered significant, with \*\*p \< 0.01, \*\*\*p \< 0.001 as determined by multiple t test using two-stage linear step-up procedure of Benjamini, Krieger, and Yekutieli with Q = 1%.(C) Quantification of HF length from control and *Egfr*^*Δep*^ mice at indicated time points. Bars show analysis of 15--20 follicles per mouse from n = 3 mice per genotype. Data are represented as mean ± SD. p values less than 0.05 were considered significant, with \*\*\*p \< 0.001 as determined by multiple t test using two-stage linear step-up procedure of Benjamini, Krieger, and Yekutieli with Q = 1%.(D) Fontana-Masson stainings of back skin sections from control and *Egfr*^*Δep*^ mice at indicated time points. Scale bars, 50 μm.(E) Immunofluorescence staining for E-Cadherin (green), K5 (red), and nuclei (blue) from control, and *Egfr*^*Δep*^ mice at E18.5. Arrow indicates anterior-to-posterior orientation of skin section. A, anterior; P, posterior.(F) Immunofluorescence staining for K14 (green) and nuclei (blue) from E18.5 control and *Egfr*^*Δep*^ mice.(G) Polar plots of angles between IFE and anterior side of HFs from E18.5 control and *Egfr*^*Δep*^ mice. Plots show analysis of 8--12 follicles per mouse from n = 3 mice per genotype. Data represent the absolute number of HFs measured at indicated angle ranges.(H) Immunofluorescence staining for P-Cadherin (green), LHX2 (red), and nuclei (blue) from control and *Egfr*^*Δep*^ mice at E18.5.(I) Immunofluorescence staining for NFATc1 (green) and nuclei (blue) from control and *Egfr*^*Δep*^ mice at P2.(J) Immunofluorescence staining for Nephronectin (NPNT, green) and nuclei (blue) from control and *Egfr*^*Δep*^ mice at P2.Scale bars, 20 μm unless otherwise stated. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

EGFR Deficiency Does Not Result in Alterations of HF Specification during Morphogenesis {#sec2.1}
---------------------------------------------------------------------------------------

First, we analyzed HF specification at late embryonic time points to investigate whether lack of EGFR may impair early HF development. Staining for E-Cadherin confirmed correct anterior-to-posterior orientation of hair pegs as detected by the absence of E-Cadherin expression at the anterior part of the HF ([@bib35], [@bib10]) in both control and *Egfr*^*Δep*^ mice ([Figure 1](#fig1){ref-type="fig"}E). Furthermore, the angle between IFE and HF was mainly similar between control and *Egfr*^*Δep*^ mice ([Figures 1](#fig1){ref-type="fig"}F and 1G). Despite HF growth differences, we did not find differences in expression of hair follicle stem cell (HFSC) fate factors in newborn mice: histological stainings for the HF progenitor/stem cell markers P-Cadherin and LHX2 ([@bib11]) ([Figure 1](#fig1){ref-type="fig"}H) and the NFATc1-positive or Nephronectin (NPTN)-positive prospective bulge region in HF ([@bib17], [@bib13]) ([Figures 1](#fig1){ref-type="fig"}I and 1J) showed robust expression and correct location of those factors in embryonic and newborn skin of *Egfr*^*Δep*^ mice. These results demonstrate that EGFR is not required to induce embryonic HFSC specification but exerts its function on proper HF morphogenesis during the growth phase.

EGFR Controls Genes Required for Epidermal Differentiation and DNA Integrity {#sec2.2}
----------------------------------------------------------------------------

To uncover the genes involved in EGFR-mediated regulation of the growth of epidermal lineages, RNA sequencing (RNA-seq) analysis was performed on sorted IFE and ORS cells from postnatal day (P)2 mice. To label ORS cells we crossed *Egfr*^*Δep*^ with *LGR5Cre*^*ERT2*^*GFP* mice to make use of LGR5-driven GFP expression as an ORS marker ([@bib20]), whereas IFE cells were defined as SCA-I^hi^ ITGA6^hi^ cells ([Figures S2](#mmc1){ref-type="supplementary-material"}A--S2C). The time point P2 was chosen, because at that stage there was still no immune cell infiltration in the skin of *Egfr*^*Δep*^ pups ([Figure S2](#mmc1){ref-type="supplementary-material"}D), but a delay in HF growth was already detectable ([Figure 1](#fig1){ref-type="fig"}B). We observed reduced GFP expression in ORS cells of *Egfr*^*Δep*^ mice at P2, although the total fraction of LGR5-expressing cells was similar to control mice ([Figures S2](#mmc1){ref-type="supplementary-material"}E--S2H). RNA-seq analysis showed strong expression of *Egfr*, *Erbb2,* and *Erbb3* in IFE and ORS of control mice, whereas there was no expression of *Erbb4*. Furthermore, we observed no or only low EGFR ligand expression in the different epidermal compartments, like low *Epgn* expression in the IFE, and low *Hb-egf* in both IFE and ORS ([Figure S2](#mmc1){ref-type="supplementary-material"}I). Analysis of differentially expressed genes between control and *Egfr*^*Δep*^ mice revealed that loss of EGFR significantly affects the expression of structural genes (*Spink5*, *Lce1e1*, *Flg*, *Sprr1a*, *Klk7*, *Gjb4*), as well as of genes regulating cell cycle and apoptosis (*Perp*, *Cep120*, *Klhdc5*, *Egr1*, *Fos*) in IFE or ORS cells ([Figures 2](#fig2){ref-type="fig"}A--2D; [Table S1](#mmc2){ref-type="supplementary-material"}A).Figure 2EGFR Controls a Variety of Genes Required for Epidermal Differentiation and DNA Integrity(A) Heatmap of significantly deregulated genes in P2 fluorescence-activated cell sorted IFE from control and *Egfr*^*Δep*^ mice. Each column represents one mouse.(B) Heatmap of significantly deregulated genes in P2 fluorescence-activated cell sorted ORS from control and *Egfr*^*Δep*^ mice. Each column represents one mouse.(C) qRT-PCR from randomly chosen target genes identified by RNA-seq from P2 IFE. Bars show data from n = 3--5 mice per genotype. Data are represented as mean ± SD. p values less than 0.05 were considered significant, with \*p \< 0.05, \*\*p \< 0.01 as determined by Student\'s t test.(D) qRT-PCR from randomly selected target genes identified by RNA-seq from P2 ORS. Bars show data from n = 3--5 mice per genotype. Data are represented as mean ± SD. p values less than 0.05 were considered significant, with \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001 as determined by Student\'s t test.(E) Bar graph of the top 15 GO terms obtained from alternative splicing analysis from IFE keratinocytes.(F) Bar graph of the top 15 GO terms obtained from alternative splicing analysis from ORS keratinocytes.(G) Venn diagram of alternative splicing targets from P2 IFE and ORS cells.(H) Bar graph of the significantly enriched GO terms obtained from overlapping genes displaying alternatively spliced exons or junction sites from IFE and ORS keratinocytes.(I) Pie chart of the ratio of alternatively used exons and junction sites of genes within the GO term "cell cycle."See also [Figure S2](#mmc1){ref-type="supplementary-material"} and [Tables S1](#mmc2){ref-type="supplementary-material"}A--S1F.

EGFR Controls Alternative Splicing, which Regulates Centrosome Function and DNA Integrity {#sec2.3}
-----------------------------------------------------------------------------------------

As the list of differentially expressed genes included a variety of targets that were either already shown to be directly linked to EGFR signaling, such as *Flg* ([@bib12]), or belonged to an expected biological process, namely, epidermal development, we focused on novel targets not yet reported to regulate epidermal integrity in the context of EGFR signaling. One of those target genes was *Srsf2* ([Figure 2](#fig2){ref-type="fig"}B). The product of this gene is required for the formation of the earliest ATP-dependent splicing complex and contributes to constitutive as well as alternative splicing ([@bib14]). To functionally investigate whether lack of EGFR might affect mRNA splicing, we analyzed our RNA-seq datasets for alternative exon usage employing JunctionSeq ([@bib16]). For both compartments, IFE and ORS, we detected a high number of alternative transcripts upon comparison of control and EGFR-deficient keratinocytes. Importantly, these genes group into distinct GO terms like "intracellular signal transduction," "Wnt pathway," "cell cycle," or "organelle part" ([Figures 2](#fig2){ref-type="fig"}E and 2F, [Table S1](#mmc2){ref-type="supplementary-material"}B).

To gain more specific information from the large amount of alternatively used exons and junction sites, we focused on the 191 (11.5%) affected overlapping genes between IFE and ORS ([Figure 2](#fig2){ref-type="fig"}G, [Table S1](#mmc2){ref-type="supplementary-material"}C). GO term analysis on those overlapping targets elucidated that EGFR is required to control the "perinuclear region of cytoplasm," "cell cycle," and "death" in both IFE and ORS ([Figure 2](#fig2){ref-type="fig"}H, [Table S1](#mmc2){ref-type="supplementary-material"}D). Deeper investigation of the genes belonging to the term "cell cycle" revealed a high number of genes important in centrosome function and DNA damage repair, e.g., *Cntrl*, *Cep192*, *Clspn*, and *Bub1b* ([Table S1](#mmc2){ref-type="supplementary-material"}E), and an almost equal number of differentially used exons and junction sites ([Figure 2](#fig2){ref-type="fig"}I, [Table S1](#mmc2){ref-type="supplementary-material"}F).

EGFR Regulates Proliferation and Prevents DNA Damage in Epidermal Lineages {#sec2.4}
--------------------------------------------------------------------------

As both global gene expression and alternative splicing analysis identified genes involved in cell cycle, centrosome function, and DNA damage response we hypothesized that a strong disbalance of cell turnover or survival and apoptosis could explain the growth delay of EGFR-deficient HFs. In light of previous reports on an important function of EGFR in promotion of proliferation ([@bib15], [@bib5], [@bib53], [@bib22], [@bib28]), we functionally tested whether EGFR is required for regulating the proliferation rate of distinct keratinocyte populations. RNA-seq analysis showed downregulation of early growth response 1 (*Egr1*) in the ORS of *Egfr*^*Δep*^ mice ([Figure 2](#fig2){ref-type="fig"}B). It was previously demonstrated that *Egr1* is a downstream target of ERK signaling and involved in cell growth and proliferation ([@bib32], [@bib47]). We confirmed EGR1 protein absence in the ORS ([Figure 3](#fig3){ref-type="fig"}A), as well as strongly reduced phospho-ERK1/2 selectively in ORS cells of EGFR-deficient skin ([Figure 3](#fig3){ref-type="fig"}B). In addition, bromodeoxyuridine (BrdU) pulse-chase experiments showed reduced BrdU incorporation into EGFR-deficient ORS cells after 24h ([Figures 3](#fig3){ref-type="fig"}C and [S3](#mmc1){ref-type="supplementary-material"}A), providing evidence that EGFR signaling in the ORS is required to induce the ERK signaling cascade, leading to *Egr1* induction and cell growth or proliferation. To address whether absence of EGFR also affects proliferation in the IFE, back skin sections from various time points (P5, P8, P10) were stained for Ki67 and additionally analyzed by flow cytometry after a 4h BrdU pulse. Our results show that both numbers of Ki67^+^ cells and BrdU^+^ cells are reduced in IFE of *Egfr*^*Δep*^ mice when compared with control mice ([Figures 3](#fig3){ref-type="fig"}D, 3E, and [S3](#mmc1){ref-type="supplementary-material"}B). These data confirm previous findings ([@bib5], [@bib53], [@bib22], [@bib28]) and provide more detailed insights into the important role of EGFR in promoting proliferation of the epidermal lineage.Figure 3EGFR Controls Cell Proliferation as well as Centrosome Function and DNA Integrity(A) Immunofluorescence staining for ITGB4 (green), EGR1 (red), and nuclei (blue) from P3 control and *Egfr*^*Δep*^ mice.(B) Immunohistochemistry staining for phospho-ERK1/2 from P3 control and *Egfr*^*Δep*^ mice. Asterisk indicates hair pigmentation.(C) Quantification of BrdU^+^ ORS cells of P2 mice 24h after BrdU pulsing. Bars show analysis of 10 follicles per mouse from n = 4 mice per genotype. Data are represented as mean ± SD. p values less than 0.05 were considered significant, with \*\*\*p \< 0.001 as determined by Student\'s t test.(D) Quantification of the number of Ki67^+^ IFE nuclei from frozen back skin sections from control and *Egfr*^*Δep*^ mice at indicated time points. MF, microscopic field. Bars show analysis of 6 microscopic fields per mouse from n = 3 mice per genotype. Data are represented as mean ± SD. p values less than 0.05 were considered significant, with \*\*p \< 0.01 as determined by Student\'s t test.(E) Quantification of the number of BrdU^+^ cells from epidermal cell suspensions analyzed by fluorescence-activated cell sorting from control and *Egfr*^*Δep*^ mice at indicated time points. Bars show analysis of n = 3 mice per genotype. Data are represented as mean ± SD. p values less than 0.05 were considered significant, with \*\*p \< 0.01 as determined by Student\'s t test.(F) Immunofluorescence staining for Tubulin (green), Pericentrin (red), and nuclei (blue) from primary keratinocytes derived from control and *Egfr*^*Δep*^ mice. Arrows point to centrosomes. Scale bars, 5 μm.(G) Quantification of the percentage of primary keratinocytes harboring more than two centrosomes. Bars show analysis of 15 cells per mouse from n = 3 mice per genotype. Data are represented as mean ± SD. p values less than 0.05 were considered significant, with \*\*\*p \< 0.001 as determined by Student\'s t test.(H) Immunofluorescence staining for F-Actin (green) and nuclei (blue) of primary keratinocytes derived from P8 control and *Egfr*^*Δep*^ mice. Arrows highlight nuclear fragments. Scale bars, 5 μm.(I) Immunofluorescence staining for P-Cadherin (green), activated caspase 3 (red), and nuclei (blue) from control and *Egfr*^*Δep*^ mice at E18.5, showing IFE (top) and HF (bottom).(J) Immunofluorescence staining for ITGB4 (green), activated caspase 3 (red), and nuclei (blue) from control and *Egfr*^*Δep*^ mice at P10, showing IFE (top) and HF matrix (bottom). Arrow highlights an apopotic cell.(K) Immunofluorescence staining for γH2AX (green) and nuclei (blue) from control and *Egfr*^*Δep*^ mice at P10, showing IFE (upper panel) and HF matrix (lower panel). Arrows highlight spots of DNA damage.(L) Immunohistochemical staining of TP53 on sections of P10 control and *Egfr*^*Δep*^ mice, showing HF matrix. Asterisk indicates hair pigmentation, delineated area marks dermal papilla (DP).Scale bars, 20 μm unless otherwise stated. See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

Detailed depiction of exon usage of Centriolin (*Cntrl*) ([Figure S3](#mmc1){ref-type="supplementary-material"}C) shows that EGFR-deficient keratinocytes preferentially skip exons 11, 15, and 16. Exon 11 encodes an alternative 3′ UTR and leads to a shorter transcript, which is known as a 110-kDa variant of *Cntrl* termed *Cep110*. Skipping of the alternative part of exon 11 leads to an increase in full-length transcript, encoding a 270-kDa variant of *Cntrl*, including a domain required for centrosome localization ([@bib46]). Exons 15 and 16 contribute to the stathmin domain of CNTRL, which is involved in regulation of mitotic spindle assembly. Further investigation of Claspin (*Clspn*) mRNA shows that *Egfr*^*Δep*^ mice skip exon 12 ([Figure S3](#mmc1){ref-type="supplementary-material"}D). Claspin is required for cell-cycle arrest in response to DNA damage via activation of CHK1 ([@bib25]). Interestingly, exon 12 encodes a protein region involved in forming the CHK1-activating domain (CKAD), suggesting that exon skipping leads to reduced binding of CLSPN to CHK1 and subsequently to reduced clearance of DNA damage.

To test this hypothesis, we investigated centrosome numbers, DNA damage, and apoptosis. Pericentrin stainings of primary keratinocytes revealed an increased fraction of EGFR-deficient keratinocytes displaying more than two centrosomes ([Figures 3](#fig3){ref-type="fig"}F and 3G). Moreover, we observed nuclear fragmentation in keratinocytes lacking EGFR ([Figure 3](#fig3){ref-type="fig"}H). As both, WT and *Egfr*^*Δep*^ keratinocyte cultures, were negative for the differentiation marker K1, we exclude that fragmentation of nuclei might be due to accelerated differentiation of EGFR-deficient keratinocytes ([Figure S3](#mmc1){ref-type="supplementary-material"}E). To analyze whether loss of DNA integrity is accompanied by increased cell death, we stained back skin sections for active caspase 3. Apoptotic cells were detected in the IFE and hair pegs of E18.5 epidermis ([Figure 3](#fig3){ref-type="fig"}I) as well as in P10 IFE and matrix of *Egfr*^*Δep*^ mice ([Figure 3](#fig3){ref-type="fig"}J). Furthermore, staining for the DNA damage marker γH2AX uncovered a high number of γH2AX foci in skin of *Egfr*^*Δep*^ mice, but not in control mice ([Figure 3](#fig3){ref-type="fig"}K). The presence of DNA damage was accompanied by stabilization and accumulation of TP53 in nuclei of matrix cells from *Egfr*^*Δep*^ mice ([Figure 3](#fig3){ref-type="fig"}L). These data demonstrate that absence of EGFR leads to accumulation of DNA damage, which subsequently induces TP53 stabilization and apoptosis.

Apoptosis in IFE and Matrix Is TP53 Dependent, Whereas Loss of Inner Hair Layers Is TP53 Independent {#sec2.5}
----------------------------------------------------------------------------------------------------

To investigate whether TP53-induced cell death causes impaired HF development in *Egfr*^*Δep*^ mice, we crossed *Egfr*^*Δep*^ mice with *p53*^*fl/fl*^ mice to generate *Egfr/p53*^*Δep*^ mice ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). Surprisingly, *Egfr/p53*^*Δep*^ mice presented the same phenotype as *Egfr*^*Δep*^ mice: skin and hair alterations, reduced survival, and strong skin inflammation ([Figures S4](#mmc1){ref-type="supplementary-material"}C--S4E). However, deletion of TP53 abolished apoptosis in IFE and matrix cells in *Egfr*^*Δep*^ mice at P10 ([Figures 4](#fig4){ref-type="fig"}A--4D), suggesting a TP53-dependent mechanism for cell death in these highly proliferative epidermal compartments. Upon closer investigation of other epithelial compartments in the epidermal lineage, we also detected apoptotic cells in the hair shaft of *Egfr*^*Δep*^ mice, which were, however, not affected by additional TP53 deletion ([Figures 4](#fig4){ref-type="fig"}E and 4F), providing evidence for a TP53-independent apoptotic mechanism in postmitotic cells. We could also confirm the presence of apoptosis in innermost hair layers, such as medulla cells, by transmission electron microscopy ([Figure 4](#fig4){ref-type="fig"}G). To characterize whether apoptosis in the hair shaft affects the differentiation of epithelial hair layers in mice lacking epidermal EGFR, we stained for hair-layer-specific keratins in control, *Egfr*^*Δep*^ mice, and *Egfr/p53*^*Δep*^ mice. Both *Egfr*^*Δep*^ mice and *Egfr/p53*^*Δep*^ mice exhibited onset of hair layer differentiation, but displayed an early loss of those layers ([Figure 4](#fig4){ref-type="fig"}H). These data indicate TP53-dependent cell death in proliferative keratinocytes as well as a TP53-independent mechanism of apoptosis in the non-proliferative, differentiated cells of the hair shaft upon lack of EGFR signaling.Figure 4Apoptosis in IFE and Matrix Is TP53 Dependent, whereas Loss of Inner Hair Layers Is TP53 Independent(A) Immunofluorescence staining for ITGB4 (green), activated caspase 3 (red) and nuclei (blue) from control, *Egfr*^*Δep*^, and *Egfr/p53*^*Δep*^ mice at P10, showing IFE. Arrow highlights an apoptotic cell.(B) Quantification of the number of activated caspase 3^+^ IFE cells from control, *Egfr*^*Δep*^, and *Egfr/p53*^*Δep*^ mice at P10. Bars show analysis of 10 microscopic fields per mouse from n = 3 mice per genotype. Data are represented as mean ± SD. p values less than 0.05 were considered significant, with \*p \< 0.05 as determined by Kruskal-Wallis test.(C) Immunofluorescence staining for ITGB4 Integrin (green), activated caspase 3 (red), and nuclei (blue) from control, *Egfr*^*Δep*^, and *Egfr/p53*^*Δep*^ mice at P10, showing HF matrix (Mx). Arrow highlights an apoptotic cell.(D) Quantification of the number of activated caspase 3^+^ matrix cells from control, *Egfr*^*Δep*^, and *Egfr/p53*^*Δep*^ mice at P10. Bars show analysis of 20--30 hair follicles per mouse from n = 3 mice per genotype. Data are represented as mean ± SD. p values less than 0.05 were considered significant, with \*p \< 0.05 as determined by Kruskal-Wallis test.(E) Immunofluorescence staining for ITGB4 (green), activated caspase 3 (red), and nuclei (blue) from control, *Egfr*^*Δep*^, and *Egfr/p53*^*Δep*^ mice at P10, showing hair shaft (HS). Arrows highlight apoptotic cells.(F) Quantification of the number of activated caspase 3^+^ hair shaft cells from control, *Egfr*^*Δep*^, and *Egfr/p53*^*Δep*^ mice at P10. Bars show analysis of 20--30 hair follicles per mouse from n = 3 mice per genotype. Data are represented as mean ± SD. p values less than 0.05 were considered significant, with \*p \< 0.05 as determined by Kruskal-Wallis test.(G) Transmission electron microscopic image of medulla cells from P14 control and *Egfr*^*Δep*^ mice. Scale bars, 2 μm.(H) Immunofluorescence staining for ITGB4 (green), cortex marker K31 (red), and nuclei (blue) from control, *Egfr*^*Δep*^, and *Egfr/p53*^*Δep*^ mice at P10 (far left). Immunofluorescence staining for ITGB4 (green), IRS (Henle layer) marker K71 (red), and nuclei (blue) from control, *Egfr*^*Δep*^, and *Egfr/p53*^*Δep*^ mice at P10 (middle left). Immunofluorescence staining for ITGB4 (green), cuticle marker K82 (red), and nuclei (blue) from control, *Egfr*^*Δep*^, and *Egfr/p53*^*Δep*^ mice at P10 (middle right). Immunofluorescence staining for ITGB4 (green), cuticle and cortex marker K39 (red), and nuclei (blue) from control, *Egfr*^*Δep*^, and *Egfr/p53*^*Δep*^ mice at P10 (far right). Arrows highlight disappearance of layers.Scale bars, 20 μm unless otherwise stated. See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

EGFR Controls Hair Lineage Transcription Factor Expression {#sec2.6}
----------------------------------------------------------

To investigate whether transcription factors involved in hair layer differentiation showed altered expression upon EGFR deletion, we stained for IRS-specific transcription factor GATA-3, as well as for IRS- and HS-specific factor LEF1 ([@bib33], [@bib21], [@bib1]). GATA-3 expression was not different between control and *Egfr*^*Δep*^ mice ([Figure 5](#fig5){ref-type="fig"}A). However, LEF1 was only found to be expressed in IRS cells of *Egfr*^*Δep*^ mice, but not in hair shaft cells ([Figure 5](#fig5){ref-type="fig"}B). Staining for trichohyalin AE15, which is present in differentiated IRS and medulla, revealed lack of properly differentiated medulla cells in *Egfr*^*Δep*^ mice ([Figure 5](#fig5){ref-type="fig"}C).Figure 5EGFR Controls Hair Lineage Transcription Factor Expression(A) IHC staining of GATA-3 from P10 control and *Egfr*^*Δep*^ mice.(B) Immunofluorescence staining for P-Cadherin (green), LEF1 (red), and nuclei (blue) from P10 control and *Egfr*^*Δep*^ mice. Arrowheads point to hair shaft cells.(C) Immunofluorescence staining for ITGB4 (green), IRS and medulla marker AE15 (red), and nuclei (blue) from control and *Egfr*^*Δep*^ mice at P10. Arrowheads point on medulla cells.(D) Model summarizing TP53-dependent mechanisms of cell death in IFE, ORS, and medulla during the growth phase of HF morphogenesis in *Egfr*^*Δep*^ mice.(E) Model summarizing TP53-independent effects of EGFR deficiency in epithelial hair lineages.Scale bars, 20 μm unless otherwise stated.

Based on our results, we propose that EGFR signaling affects spatial layering during HF growth and differentiation ([Figures 5](#fig5){ref-type="fig"}D and 5E). First, EGFR promotes cell proliferation and ensures DNA integrity in highly proliferative epidermal compartments, such as IFE, ORS, and matrix. Upon loss of EGFR in those compartments, accumulation of DNA damage mediates TP53-dependent apoptosis ([Figure 5](#fig5){ref-type="fig"}D). Second, EGFR controls hair-layer-specific transcription factor expression to regulate epithelial hair layer specification and differentiation. EGFR deficiency leads to absence of proper differentiation cues for hair shaft cells, resulting in TP53-independent loss of the medulla layer ([Figure 5](#fig5){ref-type="fig"}E).

Loss of EGFR in Adult HFSCs Results in Growth Delay {#sec2.7}
---------------------------------------------------

We next investigated whether EGFR also serves a growth-promoting function in adult HFSCs. Therefore, we first tested whether EGFR is expressed in adult HFSCs by applying fluorescently labeled epidermal growth factor to cell suspensions of adult (P45) wild-type mice after completion of the first hair cycle, when hair is in early telogen. We detected high EGFR expression in CD34^+^ old and new bulge stem cells, intermediate expression in IFE, and no expression in CD45^+^ hematopoietic cells using flow cytometric analysis ([Figure S5](#mmc1){ref-type="supplementary-material"}A). These results were confirmed by EGFR stainings on back skin sections ([Figure S5](#mmc1){ref-type="supplementary-material"}B). Furthermore, EGFR expression was detected within the matrix, the ORS and the IRS of anagen HFs ([Figures S5](#mmc1){ref-type="supplementary-material"}C and S5D). During catagen, scattered EGFR expression was observed in the retracting HF ([Figure S5](#mmc1){ref-type="supplementary-material"}E). These results suggest that EGFR signaling is required in adult HFSCs. Because it is not possible to investigate activation and growth of adult HFSCs in *Egfr*^*Δep*^ mice owing to HF degradation and progressive hair loss ([@bib27]), we crossed *Egfr*^*fl/fl*^ to *Lgr5Cre*^*ERT2*^*GFP* mice to delete the EGFR after completion of the first postnatal hair cycle (from P43-P47) in lower bulge and secondary hair germ (2°HG) HFSCs by tamoxifen injection (EGFR^ΔLGR5−ERT2^ mice, [Figure S5](#mmc1){ref-type="supplementary-material"}F). *Egfr*^*ΔLGR5-ERT2*^ mice were monitored during progression of the second postnatal hair cycle until P88. EGFR deletion was confirmed by genomic DNA ([Figure S5](#mmc1){ref-type="supplementary-material"}G) and by immunohistochemistry (IHC) analysis ([Figure S5](#mmc1){ref-type="supplementary-material"}H). *Egfr*^*ΔLGR5-ERT2*^ mice exhibited delayed entry into the second hair cycle ([Figure 6](#fig6){ref-type="fig"}A), demonstrating that EGFR signaling is involved in HFSC activation and proliferation. This was further underlined by the finding that by the time of analysis most follicles of control mice had completed the second hair cycle and already returned to telogen, whereas the majority of HFs of *Egfr*^*ΔLGR5-ERT2*^ mice was still in anagen of the second cycle ([Figure 6](#fig6){ref-type="fig"}B). Importantly, *Egfr*^*ΔLGR5-ERT2*^ mice did not display an immune cell infiltrate ([Figure 6](#fig6){ref-type="fig"}C), emphasizing that the growth delay observed in *Egfr*^*ΔLGR5-ERT2*^ mice is solely due to cell-autonomous defects in HFSCs.Figure 6Loss of EGFR in Adult HFSCs Results in Growth Delay(A) Photographs of shaved back skin from control and *Egfr*^*ΔLGR5*^ mice before and during anagen of second hair cycle.(B) Quantification of percentage of anagen HFs in mice of indicated genotypes at P88. Bars show analysis of 10 hair follicles per mouse from n = 7--8 mice per genotype. Data are represented as mean ± SD. p values less than 0.05 were considered significant, with \*\*\*p \< 0.001 as determined by Student\'s t test.(C) Quantification of CD45^+^ cells in P88 control and *Egfr*^*ΔLGR5*^ mice. Bars show analysis of n = 3--5 mice per genotype. Data are represented as mean ± SD. p values less than 0.05 were considered significant. The data sets do not show staticstical significance as determined by Student\'s t test.(D) Heatmap of significantly deregulated genes between P88 control and *Egfr*^*ΔLGR5*^ mice. Each column represents one mouse.(E) Graphical representation of qRT-PCR validation of randomly selected target genes from LGR5^+^ cells of P88 control and *Egfr*^*ΔLGR5*^ mice. Bars show analysis of n = 4 mice per genotype. Data are represented as mean ± SD. p values less than 0.05 were considered significant, with \*p \< 0.05, \*\*p \< 0.01 as determined by Student\'s t test.(F) Bar diagram of GO terms of significantly deregulated genes.(G) Heatmap of deregulated genes belonging to GO Term "growth." Each column represents one mouse.(H) Model depicting the effects of EGFR in adult HFSCs.See also [Figure S5](#mmc1){ref-type="supplementary-material"} and [Tables S2](#mmc3){ref-type="supplementary-material"}A--S2F.

To identify molecules deregulated in adult HFSCs upon loss of EGFR, we performed flow cytometric cell sorting of LGR5^+^ cells from P88 control and *Egfr*^*ΔLGR5-ERT2*^ mice and subjected them to RNA-seq ([Figures S5](#mmc1){ref-type="supplementary-material"}I and S5J). We found 145 genes to be significantly differentially expressed between LGR5^+^ cells derived from control and *Egfr*^*ΔLGR5-ERT2*^ mice ([Figures 6](#fig6){ref-type="fig"}D and 6E, [Table S2](#mmc3){ref-type="supplementary-material"}A). Among the differentially expressed genes, we found genes encoding for structural proteins that were deregulated in our dataset obtained from P2 *Egfr*^*Δep*^ mice such as *Gjb4* and *Klk7* and also genes encoding for signaling and growth molecules such as *Wnt3a* or *Bmp7* indicating that lack of EGFR signaling in LGR5^+^ HFSCs broadly shifts the balance of molecules regulating HFSC behavior. Overall, affected genes show enrichment for GO terms such as "cellular response to chemical stimulus," "tissue development," "molting cycle," or "growth" ([Figures 6](#fig6){ref-type="fig"}F and 6G, [Tables S2](#mmc3){ref-type="supplementary-material"}B and S2C). Thus loss of EGFR negatively alters the susceptibility of HFSCs to respond to activating cues ([Figure 6](#fig6){ref-type="fig"}H).

Investigation of receptor and ligand expression in control LGR5^+^ HFSCs revealed that similar to P2 IFE and ORS, these cells highly express *Egfr*, *Erbb2,* and *Erbb3*, but not *Erbb4*. Moreover, LGR5^+^ HFSCs display low expression of the ligands *Tgfα*, *Epgn,* and *Hb-egf*, whereas all other ligands are not expressed ([Figure S5](#mmc1){ref-type="supplementary-material"}K).

Furthermore, exons or junction sites of more than 300 genes were affected by alternative splicing alterations in LGR5^+^ cells of Lgr5^+^ *Egfr*^*ΔLGR5-ERT2*^ mice, enriching for GO terms associated with cell stimulation and intracellular metabolic processes ([Figure S5](#mmc1){ref-type="supplementary-material"}L, [Table S2](#mmc3){ref-type="supplementary-material"}D). Notably, we detected a substantial overlap of alternative transcripts from 213 genes (10.3%) between P2 IFE + ORS and P88 LGR5^+^ cells ([Figure S5](#mmc1){ref-type="supplementary-material"}M, [Table S2](#mmc3){ref-type="supplementary-material"}E), leading to the assumption that EGFR has some identical targets in distinct epidermal compartments at different time points, as well as a variety of specific targets depending on epidermal cell identity and age. Shared target genes display significant enrichment for GO terms such as "organelle," "intracellular signal transduction," and "cell cycle" ([Figure S5](#mmc1){ref-type="supplementary-material"}N, [Table S2](#mmc3){ref-type="supplementary-material"}F), further underlining that EGFR is required for proliferation and proper orchestration of molecules and pathways involved in both HF development and adult HFSC activation and new HF growth.

Discussion {#sec3}
==========

Our study demonstrates that the phenotype of EGFR-deficient skin is multifactorial, displaying alterations in expression of structural proteins, DNA integrity and DNA damage, proliferation, and apoptosis, but not stem cell identity genes. Lack of EGFR in newborn skin reduces proliferation in ORS and also in IFE keratinocytes. Analysis of RNA-seq data and subsequent histological analysis demonstrate reduced ERK activation and loss of expression of the ERK downstream target *Egr1* ([@bib32], [@bib47]) in EGFR-deficient ORS. In various studies on cancer cells and in mouse models of ERBB2 overexpression a prominent function of EGFR signaling in promoting keratinocyte proliferation via ERK phosphorylation has been shown ([@bib28]) ([@bib5], [@bib53], [@bib22]). The proliferation-promoting function of EGFR was mainly assessed in a hyperproliferative context of tumor cells, whereas only little information is available in the framework of epidermal morphogenesis and homeostasis. Albeit a reduction of proliferating keratinocytes was shown for the IFE of *Egfr*^*−/−*^ mice ([@bib15]), this was never formally shown for the ORS. Importantly, previous studies investigating adult EGFR-deficient mice could not show changes in pERK by using *in vitro* assays ([@bib37]) or *in vivo* analysis ([@bib52]). The absence of effects on pERK levels might be due to assessment of fully developed adult murine skin, and not neonatal mice, undergoing epidermal morphogenesis. In addition, many other pathways have been shown to induce ERK phosphorylation in keratinocytes. Thus our data provide new insight into a growth-promoting function of EGFR in the developing ORS.

We assessed the specification of committed HFSC populations during early HF development by using markers LHX2, NFATc1, and NPNT. All factors were equally expressed and localized in control and *Egfr*^*Δep*^ mice. Among the group of epidermal structural genes displaying differential gene expression in our RNA-seq dataset were factors that each alone can result in severe epidermal or hair alterations: mutations in *Flg* are known to be involved in the development of atopic dermatitis ([@bib48]), mutations in *Spink5* are reported to cause Netherton syndrome ([@bib41]), and mutations in *Gjb4* are associated with erythrokeratodermia variabilis ([@bib42]). These findings demonstrate that one critical role of EGFR signaling is transcriptional regulation of structural genes directly involved in epidermal differentiation.

We identified centrosome assembly and function as a novel downstream process of EGFR signaling by our expression and alternative splicing analysis. IFE keratinocytes lacking EGFR display centrosome amplifications. Functional consequences of abnormal centrosome numbers due to a disbalance in centrosomal proteins were previously shown to correlate with genome instability ([@bib51], [@bib39]). Importantly, defects in centrosome or mitotic spindle assembly leading to the generation of multiple nuclei are partially causative for the rare disease trichothiodystrophy ([@bib38], [@bib54]), which affects DNA repair and hair structure.

Generally, genome instability and nuclear fragmentation are accompanied by DNA damage. In the epidermis, centrosome amplifications result in impaired mitosis and TP53-mediated cell death ([@bib24]). In our datasets, we find transcriptional upregulation of genes associated with cellular response to DNA damage in *Egfr*^*Δep*^ mice: TP53 apoptosis effector *Perp* is known as an apoptosis-associated target of TP53, involved in its stabilization ([@bib2], [@bib9]), and *Hmgn2* was reported to facilitate chromatin accessibility for DNA repair machinery ([@bib45]). So far, cross talk between EGFR and TP53 signaling was only shown *in vitro* ([@bib23]). Importantly, our data for the first time provide *in vivo* evidence for a role of EGFR signaling in prevention of DNA damage in proliferating cells and for susceptibility of epidermal cells to TP53-mediated apoptosis upon loss of EGFR. Despite the DNA-damage-induced apoptosis in proliferative keratinocyte compartments, we detect TP53-independent cell loss in differentiated epithelial hair layers comprising the hair shaft. Suprabasal-transit-amplifying cells, which give rise to those innermost hair layers, display a requirement for EGFR signaling to induce correct transcription factor expression of the lineage diversification factor *Lef1*. During morphogenesis, LEF1 protein is not detectable in hair shaft cells of EGFR-deficient epidermis, thus presumably reducing the expression of hair-shaft-specific genes. These defects ultimately lead to loss of hair shaft cells, hair structure alteration, and hair malformation.

Limitation of the Study {#sec3.1}
-----------------------

We are formally not able to discriminate between a cell-autonomous function of EGFR in epithelial hair lineage differentiation, or a secondary effect on hair shaft differentiation following absence of EGFR in all epithelial skin lineages. To date, there are no-hair shaft-specific Cre lines available that would allow detailed investigation of the effects of *Egfr* deletion in these particular hair lineages.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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